| Effectiveness of Influenza Vaccine Reminder Systems (NCT01852656) | Kaiser Permanente | 2012-09-01 |
| Real Life Effectiveness of Easyhaler (Orion) (NCT02048930) | Research in Real-Life Ltd | 2012-09-01 |
| Healthy Eating Better Breathing: A Feeding Study in Patients With Asthma (NCT02904655) | Johns Hopkins University | 2012-09-01 |
| Aura Adolescent PK Study GSK2829332 (NCT01653483) | GlaxoSmithKline | 2012-09-01 |
| Implementation of ACT Through Facebook for Teenagers With Asthma (NCT01675921) | Massachusetts General Hospital | 2012-09-01 |
| Safety and Efficacy of WIN-901X in Asthma (NCT01820481) | Whanin Pharmaceutical Company | 2012-09-01 |
| Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication (NCT01696071) | Boehringer Ingelheim | 2012-09-01 |
| Assessment of Activity Limitation in Asthma Patients (NCT01962142) | Centre Hospitalier Universitaire Saint Pierre | 2012-09-01 |
| Airway Inflammation and Remodeling in Asthma and COPD. (NCT02069054) | Medical University of Warsaw | 2012-09-01 |
| T Cell Effector and Regulatory Mechanisms in Asthma (NCT01612936) | Andrew D. Luster, M.D.,Ph.D. | 2012-09-01 |
| Environmental Polymorphisms Registry Health and Exposures Survey (NCT01688986) | National Institute of Environmental Health Sciences (NIEHS) | 2012-08-25 |
| A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012) (NCT01656395) | Merck Sharp & Dohme LLC | 2012-08-23 |
| A Four-way Crossover, Single and Repeat Dose Study to Determine the Dose Proportionality and Absolute Bioavailability of Fluticasone Furoate Inhalation Powder Administered by Novel Dry Powder Inhaler (NDPI) (NCT01669070) | GlaxoSmithKline | 2012-08-15 |
| Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011) (NCT01624974) | Merck Sharp & Dohme LLC | 2012-08-09 |
| A Study of Inhaler Use in the Community (NCT02552472) | Beaumont Hospital | 2012-08-01 |
| Understanding and Appraising the New Medicine Service in England (NCT01635361) | University of Nottingham | 2012-08-01 |
| Prehospital Emergency Care of Obstructive Respiratory Emergencies With the Use of Teleconsultation (NCT01644045) | RWTH Aachen University | 2012-08-01 |
| Equivalence of a Human-Powered Nebulizer to an Electric Nebulizer (NCT01795742) | Marquette University | 2012-08-01 |
| Inhaled Steroids at Discharge After Emergency Department Visits for Children With Uncontrolled Asthma (NCT01881412) | Rhode Island Hospital | 2012-08-01 |
| Pharmacokinetic Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers (NCT01668121) | Orion Corporation, Orion Pharma | 2012-08-01 |
| Evaluation of Halotherapy as Asthma Treatment in Children (NCT02772341) | Rambam Health Care Campus | 2012-08-01 |
| Efficacy, Safety and Pharmacokinetics of Indacaterol Acetate in Patients With Persistent Asthma (NCT01609478) | Novartis Pharmaceuticals | 2012-08-01 |
| Study of the Effect of Innate on the Inflammatory Response to Endotoxin (NCT01143480) | National Institute of Environmental Health Sciences (NIEHS) | 2012-07-30 |
| Effect of Positive Airway Pressure on Reducing Airway Reactivity in Patients With Asthma (CPAP) (NCT01629823) | American Lung Association Asthma Clinical Research Centers | 2012-07-01 |
| Biological Monitoring of Nano Sized Particles in the Airways of Asthmatic Children (NCT01754948) | Tel-Aviv Sourasky Medical Center | 2012-07-01 |
| Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma (NCT01634139) | Boehringer Ingelheim | 2012-07-01 |
| A Study in Patients With Asthma (NCT01570478) | Chiesi Farmaceutici S.p.A. | 2012-07-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1021958 in Otherwise Healthy Controlled Asthmatic Subjects (NCT01629849) | Boehringer Ingelheim | 2012-07-01 |
| Safety and Efficacy of Mometasone Furoate Delivered Via Concept1 Device or Twisthaler® Device in Adult and Adolescent Patients With Persistent Asthma (NCT01555151) | Novartis Pharmaceuticals | 2012-07-01 |
| Effect of Aerobic Training in Moderate or Severe Asthmatic Patients (NCT02033122) | Instituto de Investigação em Imunologia | 2012-07-01 |
| A Phase 2a, Efficacy and Safety Study of Duvelisib in Mild Asthmatic Subjects (NCT01653756) | SecuraBio | 2012-07-01 |
| Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma (NCT01634113) | Boehringer Ingelheim | 2012-07-01 |
| WEUSRTP4850: Phase II: ICS/LABA Use in Pregnancy and Outcomes (NCT01681979) | GlaxoSmithKline | 2012-07-01 |
| Asthma and Indoor-air: Reducing Exposures (NCT01869543) | University of California, Davis | 2012-07-01 |
| Vitamin D, Steroids, and Asthma in African American Youth (NCT01647399) | Robert J. Freishtat | 2012-07-01 |
| Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma (NCT01634152) | Boehringer Ingelheim | 2012-07-01 |
| ENLaCE Pilot Study (NCT01641211) | University of North Carolina, Chapel Hill | 2012-07-01 |
| The Electronic Asthma Action Plan System for Implementation in Primary Care (NCT01070095) | Unity Health Toronto | 2012-07-01 |
| A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma (NCT01591044) | Rigel Pharmaceuticals | 2012-07-01 |
| Multiple Rising Dose Study of BI 144807 Powder in Bottle in Mild Asthmatic Patients (NCT01651598) | Boehringer Ingelheim | 2012-07-01 |
| A Pilot and Feasibility Study of Mobile-Based Asthma Action Plans (NCT01514760) | Arkansas Children's Hospital Research Institute | 2012-06-01 |
| Effects of Su-Huang Antitussive Capsule on Cough Variant Asthma (NCT01584804) | The First Affiliated Hospital of Guangzhou Medical University | 2012-06-01 |
| Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis (NCT01577628) | Cosmetique Active International | 2012-06-01 |
| A Phase 1, Open-label Study to Investigate the Pharmacokinetics of Tralokinumab (CAT-354) in Adolescents With Asthma (NCT01592396) | MedImmune LLC | 2012-06-01 |
| Glasgow Asthma and Allergy Study (NCT01618318) | National Services for Health Improvement Ltd | 2012-06-01 |
| INCAS - Integrated Care of Asthma in Switzerland (NCT02425293) | Cantonal Hosptal, Baselland | 2012-06-01 |
| A Study to Explore the Utility of Fractional Exhaled Nitric Oxide (FeNO) Compared With Methacholine Challenge (MCC) Testing in the Assessment of Patients With Suspected But Undiagnosed Asthma (NCT01648920) | Aerocrine AB | 2012-06-01 |
| Effects of Montelukast on Airway Regulatory T Cells in Asthma (NCT01951898) | Kurume University | 2012-06-01 |
| Study of Inhaled RNS60 in Combination With Budesonide to Treat Mild to Moderate Asthma (NCT01511302) | Revalesio Corporation | 2012-06-01 |
| Pharmacokinetic Study Comparing Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler Forte (NCT01627158) | Orion Corporation, Orion Pharma | 2012-06-01 |
| Asthma Comparative Effectiveness Study (NCT01623544) | AstraZeneca | 2012-06-01 |
| A Placebo and Active Controlled Study of ONO-6950 Following Allergen Challenge in Patients With Asthma (NCT01551147) | Ono Pharma USA Inc | 2012-06-01 |
| Mechanism and Dynamics of Bronchial Hyper-reactivity to Methacholine in Distal Airway on Obese Patients With Asthma (NCT03102749) | University Hospital, Montpellier | 2012-06-01 |
| mRNA Expression as a Biomarker of Omalizumab Response (NCT01584687) | Instituto de Investigação em Imunologia | 2012-06-01 |
| Efficacy and Safety Study to Compare Formoterol Fumerate in the Pressair DPI to the Foradil Aerolizer in Patient With Mild to Moderate Asthma (NCT01641081) | AstraZeneca | 2012-06-01 |
| Efficacy and Safety of Mometasone Furoate for Persistent Asthma Previously Treated With Low-Dose Inhaled Glucocorticosteroids (ICS) (Study P06115) (NCT01026870) | Organon and Co | 2012-06-01 |
| Effects of Multidisciplinary Interventions in Elderly Asthma Patients With Risk of Acute Exacerbation (NCT01843439) | Sang-Heon Cho | 2012-06-01 |
| An Open Label Placebo Study to Assess the Inhalation Profile in Asthmatic Patients Using the Nexthaler® Dry Powder Inhaler (DPI) Device (NCT01651650) | Chiesi Farmaceutici S.p.A. | 2012-06-01 |
| Asthma Data Innovation Demonstration Project (NCT02162576) | David Van Sickle | 2012-06-01 |
| Improving Household Air Quality in Homes With Children (NCT01634334) | San Diego State University | 2012-05-01 |
| Inhibitory Receptors in Eosinophils of Atopic Subjects (NCT01489293) | Meir Medical Center | 2012-05-01 |
| Launching an Asthma Initiative Designed to Improve Asthma Management and Outcomes (NCT02140671) | Research in Real-Life Ltd | 2012-05-01 |
| Small Airways Disease in Asymptomatic and Symptomatic Subjects With Airway Hyperresponsiveness (AHR) (NCT01549483) | University Medical Center Groningen | 2012-05-01 |
| Smoking Cessation Intervention in Respiratory Inpatients (NCT02922387) | General Hospital of Kavala | 2012-05-01 |
| The Identification of Different Lung Diseases by Analysis of Volatile Organic Compounds in Breath Samples (NCT01631162) | Carmel Medical Center | 2012-05-01 |
| My MediHealth: A Paradigm for Children-centered Medication Management (NCT01730235) | Vanderbilt University | 2012-05-01 |
| Effectiveness of Pharmacist Interventions in Difficult Asthma (NCT02363192) | The Leeds Teaching Hospitals NHS Trust | 2012-05-01 |
| The Development of a Clinical Test to Assess the Inflammatory Phenotype of Asthma (NCT01611012) | Prof. Jan-Willem Lammers MD PhD | 2012-05-01 |
| Imaging Study of the Lungs During an Allergic Asthma Attack (NCT01547286) | Massachusetts General Hospital | 2012-05-01 |
| A Mechanistic Study to Evaluate the Efficacy of Montelukast on Airway Function in Asthma (NCT01841164) | Karolinska University Hospital | 2012-05-01 |
| International Cross-sectional and Longitudinal Assessment on Asthma Control (Liaison) (NCT01567280) | Chiesi Farmaceutici S.p.A. | 2012-05-01 |
| Prediction of Future Risk in Patients With Controlled Asthma (NCT01565031) | Luis Perez de Llano | 2012-05-01 |
| Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts (NCT01608243) | Stallergenes Greer | 2012-05-01 |
| Comparison of Absorption of Budesonide and Formoterol From Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler (NCT01593826) | Orion Corporation, Orion Pharma | 2012-05-01 |
| A 3-period Crossover Study With GSK573719 as Monotherapy in Adult Subjects With Asthma (NCT01641692) | GlaxoSmithKline | 2012-05-01 |
| Efficacy and Safety of CHF 1535 200/6µg in Not Adequately Controlled Asthmatic Patients (NCT01577082) | Chiesi Farmaceutici S.p.A. | 2012-04-20 |
| Beta Blocker Therapy in Mild to Moderate Asthmatics (NCT01544634) | University of Dundee | 2012-04-04 |
| Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma (NCT01573624) | GlaxoSmithKline | 2012-04-03 |
| A Study of ARRY-502 in Patients With Persistent Asthma (NCT01561690) | Pfizer | 2012-04-02 |
| Study to Assess the Effect of the NEXThaler® Device (DPI - Dry Powder Inhaler) on the Central and Peripheral Airway Dimensions in Asthmatic Patients (NCT01650441) | University Hospital, Antwerp | 2012-04-01 |
| Breathing & Mild Physical Exercise Therapy for Asthma (NCT01509443) | Dasman Diabetes Institute | 2012-04-01 |
| Safety, Tolerability, and Pharmacokinetics After a Single Dose of Orally Inhaled DNAzyme Solution for Nebulisation in Male Patients With Asthma (NCT01577953) | Sterna Biologicals GmbH & Co. KG | 2012-04-01 |
| Effectiveness of the Propeller Health (Formerly Asthmapolis) Monitoring System (NCT01509183) | Reciprocal Labs | 2012-04-01 |
| A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA) (NCT01582503) | Genentech, Inc. | 2012-04-01 |
| A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications (NCT01576718) | Teva Branded Pharmaceutical Products R&D, Inc. | 2012-04-01 |
| Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety Evaluation (NCT01581177) | Amphastar Pharmaceuticals, Inc. | 2012-04-01 |
| Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children (NCT01573767) | GlaxoSmithKline | 2012-04-01 |
| D-tecting Disease - From Exposure to Vitamin D During Critical Periods of Life (NCT03330301) | Bispebjerg Hospital | 2012-04-01 |
| Effect of an add-on Treatment With Ivy Leaves Dry Extract on Lung Function in Bronchial Asthma (NCT01692041) | Technische Universität Dresden | 2012-04-01 |
| Safety, Tolerability, and Pharmacokinetics After Multiple Doses of Orally Inhaled DNAzyme Solution for Nebulisation in Healthy Male Subjects (NCT01554319) | Sterna Biologicals GmbH & Co. KG | 2012-04-01 |
| A Dose-ranging Study of Fluticasone Furoate (FF) (NCT01563029) | GlaxoSmithKline | 2012-03-28 |
| TGF-(Beta) and Susceptibility to RSV (NCT01224691) | National Institute of Environmental Health Sciences (NIEHS) | 2012-03-19 |
| Long-acting Beta Agonist Step Down Study (NCT01437995) | Johns Hopkins University | 2012-03-01 |
| 12-Week Study in Adult Subjects With Asthma (NCT01516073) | Dey | 2012-03-01 |
| A 12-Week Study in Adult Subjects With Asthma (NCT01516086) | Dey | 2012-03-01 |
| A Placebo and Active Controlled Study of ONO-6950 in Asthmatic Patients (NCT01536041) | Ono Pharma USA Inc | 2012-03-01 |
| A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE) (NCT01545453) | Genentech, Inc. | 2012-03-01 |
| Comparison of Flutiform, Fluticasone and Seretide in Treatment of Moderate to Severe Asthma in Paediatric Patients (NCT01511367) | Mundipharma Research Limited | 2012-03-01 |
| WEUKBRE5554: IMI PROTECT(Work Package 2): Beta2 Agonists and Acute Myocardial Infarction (NCT01636726) | GlaxoSmithKline | 2012-03-01 |
| The Impact of Implementing a Nursing-driven Clinical Pathway for Inpatient Management of Children With Asthma (NCT02037841) | Children's Hospital of Eastern Ontario | 2012-03-01 |